Press Releases

    • September 27, 2022

    Nemaura and EVERSANA sign preliminary agreement for large-scale launch of Nemaura’s Diabetes Management Program in the U.S.

    CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on...

    Read more
    August 15, 2022

    Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update

    Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    July 21, 2022

    Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program

    Loughborough, England – July 21, 2022 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    June 30, 2022

    Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022

    Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    May 23, 2022

    Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

    Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on...

    Read more
    February 28, 2022

    Nemaura Medical Wins Innovation Awards

    Loughborough, England, Feb. 28, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    February 14, 2022

    Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update

    Loughborough, England, Feb. 14, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    January 11, 2022

    Nemaura Medical Appoints Dr Arash Ghadar as Chief Operating Officer

    Loughborough, England – January 10, 2022 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    January 7, 2022

    Nemaura Medical to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

    Loughborough, England, Jan. 07, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on...

    Read more
    December 7, 2021

    Nemaura Medical Completes Initial Shipment of CGM Devices to UK Licensee

    Sales in UK expected to be followed by launches across major EU territories in 2022 Loughborough, England, Dec. 07,...

    Read more